EU approves AstraZeneca vaccine for use
Updated / Friday, 29 Jan 2021
20:16
AstraZeneca requested market authorisation through the EMA on 11 January
The European Commission has approved the AztraZeneca/Oxford Covid-19 vaccine for use, the final step to allowing Europe to use it across the continent. I expect the company to deliver the 400 million doses as agreed, Commission President Ursula von der Leyen, wrote on Twitter.
We have just authorised the @AstraZeneca vaccine on the EU market following a positive assessment by @EMA News
I expect the company to deliver the 400 million doses as agreed. We will keep on doing all we can to secure vaccines for Europeans, our neighbours & partners worldwide
An announcement is expected early this afternoon from the EMA on whether to give full approval to the AstraZeneca vaccine, including to over 65s.
If it gets the go-ahead, the vaccine from AstraZeneca would be the third in Europe added to the arsenal in the battle against Covid-19.
But as a row is rumbling on between the manufacturer and the European Commission about supply and delivery commitments.
The Health Service Executive said at its weekly briefing yesterday that it will listen to the decision from the European Medicines Agency (EMA) after a German vaccination committee recommended the AstraZeneca vaccine should not be used in people aged over 65.
黃適卓觀點：疫苗開發進度全解析，台灣民眾團結抗疫！-風傳媒 storm.mg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from storm.mg Daily Mail and Mail on Sunday newspapers.
日媒：阿斯利康授權日本生產超過9000萬劑新冠疫苗 sina.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.tw Daily Mail and Mail on Sunday newspapers.